Evidence map›Paper›PMID 37049866›Full record

ArticleMolecules (Basel, Switzerland)2023

Designing Click One-Pot Synthesis and Antidiabetic Studies of 1,2,3-Triazole Derivatives.

Kainat Shafique, Aftab Farrukh, Tariq Mahmood Ali, Sumera Qasim, Laila Jafri, Hisham S M Abd-Rabboh, Murefah Mana Al-Anazy, Saima Kalsoom

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. ACS omega · 2024
    Article
  6. Synthesis, cytotoxicity andFuture medicinal chemistry · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

Kainat ShafiqueSA-Center for Interdisciplinary Research in Basic Sciences, International Islamic University, Islamabad 44000, Pakistan.
Aftab FarrukhDepartment of Physics, PMAS-Arid Agriculture University, Rawalpindi 44000, Pakistan.
Tariq Mahmood AliHealth Services Academy, Islamabad 44000, Pakistan.
Sumera QasimDepartment of Pharmacology, College of Pharmacy, Jouf University, Sakaka 72431, Saudi Arabia.ORCID 0000-0002-6082-6889
Laila JafriDepartment of Life Sciences, Abasyn University, Islamabad Campus, Islamabad 44000, Pakistan.
Hisham S M Abd-RabbohChemistry Department, Faculty of Science, King Khalid University, P.O. Box 9004, Abha 61413, Saudi Arabia.
Murefah Mana Al-AnazyDepartment of Chemistry, College of Sciences, Princess Nourah bint Abdulrahman University (PNU), P.O. Box 84428, Riyadh 11671, Saudi Arabia.
Saima KalsoomDepartment of Chemistry, PMAS-Arid Agriculture University, Rawalpindi 44000, Pakistan.ORCID 0000-0002-6552-4652
Pir Mehr Ali Shah Arid Agriculture University · PKAbasyn University · PKAl Jouf University · SAHealth Services Academy · PKInternational Islamic University, Islamabad · PKKing Khalid University · SAPrincess Nourah bint Abdulrahman University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, a new series of 1,2,3-triazole derivatives was synthesized via a click one-pot reaction. The synthesized compounds were found to be active during molecular docking studies against targeted protein 1T69 by using the Molecular Operating Environment (MOE) software. The designed and synthesized compounds were characterized by using FT-IR,

Indexed as

alpha-GlucosidasesHypoglycemic Agentsalpha-AmylasesGlycoside Hydrolase InhibitorsMolecular Docking SimulationMolecular StructureSpectroscopy, Fourier Transform InfraredStructure-Activity RelationshipTriazolesalpha-Amylasesalpha-GlucosidasesGlycoside Hydrolase InhibitorsHypoglycemic AgentsTriazolesantidiabetic assay molecular dockingdiabetes mellitustriazole derivatives

Identifiers

PMID37049866
PMCPMC10096114
OpenAlexW4362456936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.